Relay Therapeutics (RLAY) Target Price Raised to $25 by H.C. Wainwright

AI Summary

H.C. Wainwright has increased the stock price target for Relay Therapeutics (RLAY) to $25. This adjustment reflects the research firm's updated outlook on the company's growth potential and performance metrics. The new price target suggests a positive sentiment towards Relay Therapeutics' market position. Analysts' revisions can significantly influence investor perception and trading behavior.